CLINICAL_TRIALS
trial_result
· 2021-03-03
Clinical Trial Update: Accelerated Corneal Cross-linking With Different Riboflavin Solutions [Phase 3]
Summary
Phase 3 trial update evaluating accelerated corneal cross-linking with different riboflavin solutions for keratoconus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Medical University of Vienna | Conditions: Keratoconus | Phase 3 | Status: COMPLETED